Our previous studies indicated that ELS such as MS can reduce NAD+ and SIRT3 expression in the CNS in rats and that nicotinamide (NAM) administration can ameliorate these biochemical changes as well as some ELS-induced cognitive deficits19. The gene discussed is SIRT3; the disease is myeloid sarcoma.